title: [Patient informed consent on the risks of erythrocyte concentrates].
abstract: In Germany approximately 4-5 million erythrocyte concentrates are administered annually. Every transfusion fulfills the criteria for an organ transplantation and represents a measure that includes risks which must be clarified with informed consent. This article describes the legal requirements for informed consent, the content, form and the exceptions. Finally, the consequences of errors in informed consent are presented.
authors.affiliation: Anwaltsbüro Quirmbach und Partner, Robert-Bosch-Str. 12/Haus V, 56410, Montabaur, Deutschland. oehlschlaeger@ihr-anwalt.com.
authors.forename: M
authors.initials: M
authors.lastname: Oehlschläger
mesh_terms: D032962:Consent Forms; D017707:Erythrocyte Transfusion / Q000009:adverse effects* / Q000706:statistics & numerical data; D005858:Germany; D006801:Humans; D007258:Informed Consent / Q000331:legislation & jurisprudence* / Q000706:statistics & numerical data*; D016377:Organ Transplantation; D012306:Risk
keywords: Anemia; Compensation and redress; Erythrocyte concentrates; Jurisdiction; Obligation to inform